CD8A and neoplasm: Administration of the SCD1 inhibitor also increased the infiltration of CD8+ T cells into tumors in all four tumor models when analyzed by gene expression analysis by qPCR, flow cytometry and immunohistochemical analyses (figure 2A, online supplemental figure 2 and 3A left panel), although regulatory T cells were not significantly changed (online supplemental figure 3B, C).